Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalysis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Penicillium-derived monoamine oxidase enables high-concentration biocatalysis for antiviral drug intermediates, ensuring supply chain stability and cost efficiency.
Patent CN119082064B reveals mutant carbonyl reductase for Pro-Xylane. High yield, low cost, scalable biocatalysis for cosmetic manufacturers.
Patent CN112442474B reveals a robust Fusarium oxysporum lactamase for optically pure (-) gamma-lactam production, offering superior stability and cost-effective manufacturing solutions.
Advanced four-step synthesis route for Sacubitril intermediates offering high purity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN121204184A reveals high-purity biocatalytic route. Enhanced scalability and cost efficiency for pharmaceutical manufacturing supply chains.
Patent CN101368168B enables high-purity chiral alcohol production via enzyme coupling. This method offers substantial cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN1786179A details a novel dual-enzyme biocatalytic route for S-(+)-2,2-dimethylcyclopropylcarboxamide, offering superior stereocontrol and reduced environmental impact for cilastatin synthesis.
Patent CN111705068A reveals a novel ketoreductase route for high-purity (R)-EHB, offering significant cost reduction and scalability for antibiotic intermediates.
Novel whole-cell method for L-menthol synthesis offers high ee and cost efficiency. Reliable supplier for flavor and fragrance intermediates with scalable green chemistry.
Patent CN114592027A reveals a novel two-step method for Tauroursodeoxycholic Acid production, offering significant cost reduction in API manufacturing and high-purity outcomes.
Novel fission yeast reductase enables efficient D-pantolactone synthesis. Reduces cost and improves supply chain reliability for pharmaceutical and feed additive manufacturers.
Patent CN114807246A details high-efficiency enzymatic reduction for chiral alcohols, offering superior stereoselectivity and industrial scalability for pharmaceutical intermediates.
Novel enzyme mutant technology enables green cordycepin production. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN102250976A reveals an enzymatic route for chiral tert-leucine. Achieve >99% ee and significant cost reduction in pharmaceutical intermediate manufacturing with scalable green chemistry.
Novel immobilized cell method ensures high purity and cost efficiency for pharmaceutical intermediates manufacturing supply chains.
Patent CN103468757A details a green enzymatic reduction for Atazanavir intermediates, offering high purity and safer manufacturing for pharmaceutical supply chains.
Patent CN101294176B details a glucose-based biotransformation route for L-ribose. This method offers high purity and environmental benefits for pharmaceutical intermediate supply chains.
Patent CN114214375A details a novel enzymatic route for high-purity Ruxolitinib intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN106699756B reveals a stable biocatalytic route for Avibactam. Achieve significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN110358752A reveals enzymatic route for high-purity Brivaracetam intermediate. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.